Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C&G Capital (Cell & Gene Capital) is a specialized venture capital and private equity firm focused on the healthcare and life sciences sectors, with a particular emphasis on cell and gene therapies. The firm invests in innovative biotechnology companies globally, providing strategic capital and operational support to accelerate the development of transformative medical treatments. C&G Capital targets early- to growth-stage enterprises that demonstrate high potential in addressing unmet medical needs through advanced therapeutic modalities. By leveraging deep industry expertise, the firm aims to foster a robust ecosystem for the next generation of medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C&G Capital Management.